Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -.--% | -82.78% |
Apr. 29 | Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 | CI |
Apr. 22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Business Summary
Mithra Pharmaceuticals S.A. explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, the Company is now focusing on its second product Donesta®, the next-generation hormone therapy.
Mithra Pharmaceuticals S.A. also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO.
Number of employees: 270
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products
100.0
%
| 23 | 100.0 % | 67 | 100.0 % | +195.56% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Europe
76.6
%
| 9 | 41.0 % | 51 | 76.6 % | +452.76% |
International
21.1
%
| 12 | 54.6 % | 14 | 21.1 % | +14.23% |
Belgium
2.3
%
| 1 | 4.5 % | 2 | 2.3 % | +51.98% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 17-02-22 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 19-03-31 |
Fanny Rozenberg
SEC | Corporate Secretary | - | - |
Laurence Schyns
HRO | Human Resources Officer | - | 20-12-31 |
Cedric Darcis
LAW | General Counsel | - | - |
Benjamin Brands
PRN | Corporate Officer/Principal | - | 08-12-31 |
Corporate Officer/Principal | - | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 23-05-28 |
Christian Homsy
CHM | Chairman | 65 | 23-05-28 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 21-05-19 |
Founder | 75 | 99-07-07 | |
Inge Beernaert
BRD | Director/Board Member | - | 23-05-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 69,108,397 | 56,443,924 ( 81.67 %) | 0 | 81.67 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,221,815 | 4.96% | 19,941,237 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Estetra SRL
Estetra SRL Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Estetra SRL is a Belgian pharmaceutical company that develops drugs. The private company is based in Grâce-Hollogne, Belgium. |
Pharmaceuticals: Major
|
Sector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.08M | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-9.12% | 11.97B | |
-14.38% | 12.07B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- MITRA Stock
- Company Mithra Pharmaceuticals S.A.